LPCN

Lipocine Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

9

Buys

9

Sells

0

Largest Trade

$15K–$50K

Insiders

4

Institutional Funds

16

Inst. Value

$1M+

Activist Filings

1

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Patel Mahesh V.CEO and PresidentBUY$15K–$50K9K$5.03May 25, 2023
Patel Mahesh V.CEO and PresidentBUY$15K–$50K150K$0.32Mar 24, 2023
Ono Richard DanaDirectorBUY$1K–$15K4K$0.34Mar 20, 2023
Patel Mahesh V.CEO and PresidentBUY$15K–$50K50K$0.33Mar 17, 2023
Papapetropoulos SpyrosDirectorBUY$1K–$15K22K$0.47Nov 28, 2022
Patel Mahesh V.CEO and PresidentBUY$15K–$50K75K$0.39Nov 14, 2022
Patel Mahesh V.CEO and PresidentBUY$15K–$50K100K$0.41Sep 27, 2022
Fogarty KristaPrincipal Accounti…BUY$1K–$15K13K$0.86May 17, 2022
Patel Mahesh V.CEO and PresidentBUY$15K–$50K50K$0.77May 16, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 16 funds holding

FundShares
Squadron Capital Management LLC530K
Ikarian Capital, LLC200K
BlackRock, Inc.89K
GEODE CAPITAL MANAGEMENT, LLC50K
RENAISSANCE TECHNOLOGIES LLC37K
VANGUARD GROUP INC26K
STATE STREET CORP19K
DIMENSIONAL FUND ADVISORS LP12K
JANE STREET GROUP, LLC11K
UBS Group AG6K
MORGAN STANLEY751
CALDWELL SUTTER CAPITAL, INC.471
GROUP ONE TRADING LLC162
HighMark Wealth Management LLC100
SBI Securities Co., Ltd.67
Tidemark, LLC59

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Squadron Master Fund LP

SC 13G · Dec 23, 2025

8.0%

445K shares

View on Google Finance →